MedTrace Logo

Factors Impacting the Prevalence of MDR Bacteria

NCT05100407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-08-18

No results posted yet for this study

Summary

1. To determine the prevalence of multidrug resistance bacteria in patient with different infections
2. To evaluate patients' predictive risk factors of antimicrobial resistance
3. To assess the association between patients' factors and prevalence of MDR bacteria

Conditions

  • Multi-antibiotic Resistance

Sponsors & Collaborators

  • Kufa University

    lead OTHER

Principal Investigators

  • Hayder Asaad, assist. prof · college of pharmacy kufa university

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-05-01
Completion
2022-05-15

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100407 on ClinicalTrials.gov